EVOKE PHARMA INC (EVOK)

Company Profile

Evoke Pharma, Inc. is a pharmaceutical company, which engages in the development of drugs for the treatment of gastrointestinal disorders and diseases. The company is headquartered in Solana Beach, California and currently employs 4 full-time employees. The company went IPO on 2013-09-25. The firm is primarily focused on the development and commercialization of drugs to treat gastrointestinal (GI) disorders and diseases. The firm operates through the development and commercialization of the pharmaceutical products segment. Evoke is developing its product Gimoti (metoclopramide) nasal spray for the relief of symptoms in adults with acute and recurrent diabetic gastroparesis. Gimoti, is a dopamine antagonist / mixed 5-HT3 antagonist / 5-HT4 agonist with promotility and anti-emetic effects, for the relief of symptoms associated with acute and recurrent diabetic gastroparesis. Gimoti is a formulation of metoclopramide offering systemic delivery by nasal spray administration.

Company Info

EVOKE PHARMA INC

420 Stevens Avenue, Suite 370

Solana Beach CALIFORNIA 92075

P: 18583451494

CEO: David A. Gonyer

Employees: 4

Website: https://evokepharma.com/